Figure 2From: Prognostic significance of urokinase plasminogen activator and plasminogen activator inhibitor-1 mRNA expression in lymph node- and hormone receptor-positive breast cancer PAI-1 mRNA expression in relapsed and non-relapsed breast cancer patients as measured by quantitative RT-PCR. Differential PAI-1 gene expression between survivors (n = 65) and non-survivors (n = 22) with BCS as end-point (Mann-Whitney test; p < 0.0001).Back to article page